http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102639505-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
filingDate 2010-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd1fb92a2ac8c4b0c67f6390109923f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22e1d58f95fd71f96bb60962f294df05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81feefa1ed3337a8fdc420f545ae54b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9d4cecb8c75c4c2af5ba6406d289cad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f321d5f70de72e5ecab9a5b9e2c1d7d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cca1ac4a1c71f8c0e7ce5276e2b9ed4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ff13b2b547758391dedb00ca0a97ba8
publicationDate 2012-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102639505-A
titleOfInvention Pyridin-2-one compounds useful as neutrophil elastase inhibitors
abstract The present invention provides compounds of formula (I), wherein R 1 , R 3 , R 4 , R 5 , R 6 , R 7 , L, X and Y are as defined in the description; methods and intermediates for their preparation, containing Their pharmaceutical compositions and their use in therapy. The compounds are inhibitors of human neutrophil elastase.
priorityDate 2009-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009061271-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004043924-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006098683-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101490040-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101490033-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409737139
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419725284
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58218050
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID147946886
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467457324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58218044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409434069
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58218046
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411247660

Total number of triples: 45.